Impurity Control Limits

Impurity Control Limits is a regulatory science construct that specifies the maximum acceptable levels of impurities in pharmaceutical substances or products, distinguished by its role in ensuring patient safety through risk-based thresholds derived from toxicological and process-related data.

33

Publications

1K

Citations

317

Authors

102

Institutions

Publications per year

2017–2026

12

Variants

Impurity Specification Limits

Authors

317

  1. DM
    D. Mueller

    Princeton Plasma Physics Laboratory, United States

    2 publications · 51 citations

    2

    h-index

  2. SK
    S. Kaye

    Princeton Plasma Physics Laboratory, United States

    2 publications · 51 citations

    2

    h-index

  3. ED
    E. de la Luna

    Culham Science Centre, United Kingdom

    2 publications · 116 citations

    2

    h-index

  4. JP
    Joel P. Bercu

    Gilead Sciences (United States), United States

    2 publications · 70 citations

    2

    h-index

  5. RK
    R. Kaita

    Princeton Plasma Physics Laboratory, United States

    2 publications · 51 citations

    2

    h-index

1–5 of 317

Venues

  1. Journal of Nuclear Materials

    7 publications · 123 citations

    7

    h-index

  2. Nuclear Fusion

    4 publications · 131 citations

    4

    h-index

  3. Analytica Chimica Acta

    2 publications · 31 citations

    2

    h-index

  4. Organic Process Research & Development

    2 publications · 47 citations

    2

    h-index

  5. Materials science forum

    MSF · Book series · 1 publications · 26 citations

    1

    h-index

1–5